Yahoo
OTC Markets OTCID USD

FOXO Technologies Inc. (FOXO)

0.1067 +0.0067 (+6.70%)
At close: September 4 at 4:00:00 PM EDT
Chart Range Bar
Loading chart for FOXO
  • Previous Close 0.1000
  • Open 0.1200
  • Bid 0.1000 x 6602500
  • Ask 0.2199 x 517200
  • Day's Range 0.1200 - 0.1200
  • 52 Week Range 0.0000 - 28.2000
  • Volume 9,266
  • Avg. Volume 13,619
  • Market Cap (intraday) 176,920
  • Beta (5Y Monthly) 2.48
  • PE Ratio (TTM) 0.00
  • EPS (TTM) 1,654.8600
  • Earnings Date (est.) --
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

FOXO Technologies Inc. operates as a healthcare services and technology company in the United States. It operates through three segments: Healthcare, Life Science Services, and Labs. The company offers behavioral health; ancillary, including laboratory, radiology, respiratory, and pharmacy; insurance; epigenetics diagnostics and interpretation; and other services. Its technology enables the adoption of saliva-based health and wellness biomarker solutions for underwriting and risk assessment; and Bioinformatics services that provides data solutions using AI and machine learning for data analysis and processing, and quality checking for academia, healthcare, government, and pharmaceutical research customers. FOXO Technologies Inc. was founded in 2020 and is based in West Palm Beach, Florida.

www.foxotechnologies.com

192

Full Time Employees

December 31

Fiscal Year Ends

Healthcare

Sector

Recent News

View More

Performance Overview

Trailing total returns as of 9/4/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .

YTD Return

FOXO
64.43%
S&P 500 (^GSPC)
12.75%

1-Year Return

FOXO
99.26%
S&P 500 (^GSPC)
18.71%

3-Year Return

FOXO
100.00%
S&P 500 (^GSPC)
70.93%

5-Year Return

FOXO
100.00%
S&P 500 (^GSPC)
70.18%

Statistics

View More

Valuation Measures

Annual
  • Market Cap

  • Enterprise Value

  • Trailing P/E

  • Forward P/E

  • PEG Ratio (5yr expected)

  • Price/Sales (ttm)

  • Price/Book (mrq)

  • Enterprise Value/Revenue

  • Enterprise Value/EBITDA

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -25.77%

  • Return on Assets (ttm)

    7.98%

  • Return on Equity (ttm)

    -63.30%

  • Revenue (ttm)

    17.86M

  • Net Income Avi to Common (ttm)

    -26.46M

  • Diluted EPS (ttm)

    1,654.8600

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    58.41k

  • Total Debt/Equity (mrq)

    2,261.49%

  • Levered Free Cash Flow (ttm)

    -3.25M

Compare

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Company Insights

Research Reports

View More

People Also Watch

Mobilize your Website
View Site in Mobile | Classic
Share by: